Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile
Majid Assadi MD,MSc(Adv.Onc.)

@assadimajidmd

#Clinician-Scientist,#Theranostics, #MolecularImaging,#Nuclearoncology

ID: 1367195315036704769

linkhttps://www.google.com/amp/s/www.researchgate.net/profile/Majid_Assadi2/amp/9 calendar_today03-03-2021 19:29:19

56 Tweet

274 Takipçi

330 Takip Edilen

Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Our project on “Development and characterization of #PDL1 #radiotheranostics in lung cancer” just accepted. researchgate.net/publication/36…

Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

After four years, our book just published. 32 chapters ,written by leading scientists/ experts ,richly illustrated (> 600 images). We dedicated to the memory of pro. Sanjive Sam Gambhir. A gentle giant of science has left this world too early. onlinelibrary.wiley.com/doi/book/10.10…

Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Our project on #SSTR imaging for detecting biological activity of atherosclerotic #plaques just published. incentive for exploration of #theranostics to identify and treat high-risk atherosclerotic plaques in this systematic disease(#CAD). mirt.tsnmjournals.org/archives/archi…

Our project on #SSTR imaging for detecting biological activity of atherosclerotic #plaques just published. 
incentive for exploration of #theranostics to identify and treat high-risk atherosclerotic plaques  in this systematic disease(#CAD).  mirt.tsnmjournals.org/archives/archi…
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Small Animal Imaging Workshop overview on state-of-the-art small animal imaging tools including PET, SPECT, CT and optical imaging. #Preclinical t.me/preclinical_Bu…

Small Animal Imaging Workshop 

overview on state-of-the-art small animal imaging tools including PET, SPECT, CT and optical imaging. 
#Preclinical 

t.me/preclinical_Bu…
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

I'm excited to invite you to our upcoming presentation on 68Ga-#FAPI PET/CT and MIBI SPECT/CT in Interstitial Lung Disease In #EANM23. 🫁 As part of our groundbreaking research project, we believe these imaging techniques could be a total game-changer in the management of #ILDs.

I'm excited to invite you to our upcoming presentation on 68Ga-#FAPI PET/CT and MIBI SPECT/CT in Interstitial Lung Disease In #EANM23. 🫁 As part of our groundbreaking research project, we believe these imaging techniques could be a total game-changer in the management of #ILDs.
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Today, targeted #alpha therapy using #225Ac_ PSMA brought renewed hope for 6 late-stage #prostate cancer patients. Exciting clinical progress continues! Special thanks to professor Mike Sathekge for his wise counsel and support throughout.

Today, targeted #alpha therapy using #225Ac_ PSMA brought renewed hope for 6 late-stage #prostate cancer patients. Exciting clinical progress continues!
Special thanks to professor 
Mike Sathekge for his wise counsel and support throughout.
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Our study on the development and evaluation of a fully automated tool for detecting and segmenting mPCa lesions in whole-body [68Ga]Ga-#PSMA #PET came out. Hope to develop comprehensive structured report template for 68Ga-PSMA PET/CT #prostatecancer link.springer.com/article/10.100…

Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Good response to the combined 177Lu/225Ac-DOTATATE treatment in a patient with recurrent and progressive meningioma –surgery and radiation refractory.   Dizziness, weakness, convulsions, speech, and personality changes totally gone following treatment. #Meningioma #Theranostics

Good response to the combined 177Lu/225Ac-DOTATATE treatment in a patient with recurrent and progressive meningioma –surgery and radiation refractory.   Dizziness, weakness, convulsions, speech, and personality changes totally gone following treatment.

#Meningioma
 #Theranostics
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

our institute has been officially recognized as a "Comprehensive National Center of Excellence" in Nuclear Medicine and Molecular Imaging by the Ministry of Health and Medical Education. It features a preclinical imaging lab along with specialized imaging and theranostic units.

Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

We are excited to share that Esmail Jafari, our #MolecularImaging PhD candidate, successfully defended his PhD thesis on AI, #PSMAPET and #prostatecancer today. During his course, he published about 30 papers.

We are excited to share that Esmail Jafari, our #MolecularImaging PhD candidate, successfully defended his PhD thesis on AI, #PSMAPET and #prostatecancer today. During his course, he published about 30 papers.
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Dual #SSTR and #FAPI PET imaging in progressive relapsed/refractory #meningiomas showing significantly greater intensity on SSTR compared to FAPI PET. #Neurotheranostics #CIC_SNMMI

Dual #SSTR and #FAPI PET imaging in progressive relapsed/refractory #meningiomas showing significantly greater intensity on SSTR compared to FAPI PET.

#Neurotheranostics 
#CIC_SNMMI
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Successful treatment of a patient with multiple primary metachronous malignancies, including #NET in 2009, (meningioma in 2010), uterine cancer in 2017, and breast cancer in 2019. The patient received #PRRT at our center in 2016. It's essential to prioritize #PrecisionMedicine.

Successful treatment of a patient with multiple primary metachronous malignancies, including #NET in 2009, (meningioma in 2010), uterine cancer in 2017, and breast cancer in 2019. The patient received #PRRT at our center in 2016.
It's essential to prioritize #PrecisionMedicine.
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Continuing our exploration of FDG PET and FAPI PET in diagnosing #ILD, a complex fibrotic-inflammatory condition A biopsy-proven ILD case—pulmonary alveolar microlithiasis—showing positive FAPI PET but negative FDG PET, offering intriguing insights into disease characterization.

Continuing our exploration of FDG PET and FAPI PET in diagnosing #ILD, a complex fibrotic-inflammatory condition

A biopsy-proven ILD case—pulmonary alveolar microlithiasis—showing positive FAPI PET but negative FDG PET, offering intriguing insights into disease characterization.
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

68Ga-DOTA-LM3 PET/CT: A Somatostatin Receptor Antagonist in a Patient with Progressive Meningioma. Exploring new imaging approaches for better tumor characterization and management. #SSTR_Antagonist #NeuroOncology #PETCT #Meningioma

68Ga-DOTA-LM3 PET/CT: A Somatostatin Receptor Antagonist in a Patient with Progressive Meningioma. Exploring new imaging approaches for better tumor characterization and management. #SSTR_Antagonist #NeuroOncology #PETCT #Meningioma
OncoDaily (@oncodaily) 's Twitter Profile Photo

Therapeutic Potential of 68Ga/177Lu-DOTATATE in Metastatic Medullary Thyroid Carcinoma by Majid Assadi et al. Majid Assadi MD,MSc(Adv.Onc.) oncodaily.com/science/68ga-1… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #68GaDOTATATE #MTC #PRRT #ThyroidCancer

Therapeutic Potential of 68Ga/177Lu-DOTATATE in Metastatic Medullary Thyroid Carcinoma by Majid Assadi et al.
<a href="/AssadiMajidMD/">Majid Assadi MD,MSc(Adv.Onc.)</a>

oncodaily.com/science/68ga-1…

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #68GaDOTATATE #MTC #PRRT #ThyroidCancer
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

A keynote speaker at the 5th International Emirates Annual Conference& Arab Society of Nuclear medicine & Molecular Imaging in Dubai, about the latest advances in #theranostics in #meningioma — an exciting and evolving field with real potential to transform patient outcomes.

A keynote speaker at the 5th International Emirates Annual Conference&amp; Arab Society of Nuclear medicine &amp; Molecular Imaging in Dubai, about the latest advances in #theranostics in #meningioma — an exciting and evolving field with real potential to transform patient outcomes.
Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

Response durability up to 6 years in #mCRPC ; in over 150 patients, 3 individuals remained in long-term remission. “duration of response” not equal to PFS. #DOR #mCRPC #Precisionmedicine link.springer.com/article/10.100…

Majid Assadi MD,MSc(Adv.Onc.) (@assadimajidmd) 's Twitter Profile Photo

⁶⁸Ga-DOTATATE PET— the King of meningioma imaging 👑 LM3 and FAPI are rising stars, but DOTATATE still reigns supreme in management . #Meningioma #PET #DOTATATE #LM3 #FAPI #Theranostics

⁶⁸Ga-DOTATATE PET— the King of meningioma imaging 👑

LM3 and FAPI are rising stars, but DOTATATE still reigns supreme in management .

#Meningioma
 #PET
 #DOTATATE
 #LM3
#FAPI
 #Theranostics